article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

Once the target is identified, researchers work to develop a compound that can interact with it. After a promising compound has been identified, it’s tested in preclinical models to evaluate its safety and efficacy. The target could be an enzyme or receptor in the human body, or it could be an organism that causes disease.